Regal Investment Advisors LLC acquired a new stake in Tilray Inc (NASDAQ:TLRY) during the first quarter, HoldingsChannel.com reports. The fund acquired 3,072 shares of the company’s stock, valued at approximately $201,000.
Other hedge funds have also made changes to their positions in the company. Lee Financial Co bought a new position in Tilray in the first quarter valued at approximately $25,000. Quantamental Technologies LLC bought a new position in Tilray in the first quarter valued at approximately $26,000. Toronto Dominion Bank bought a new position in Tilray in the fourth quarter valued at approximately $27,000. Harel Insurance Investments & Financial Services Ltd. bought a new position in Tilray in the fourth quarter valued at approximately $71,000. Finally, Bronfman E.L. Rothschild L.P. boosted its stake in Tilray by 7,266.7% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,105 shares of the company’s stock valued at $78,000 after acquiring an additional 1,090 shares during the last quarter. 6.18% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts have recently weighed in on the stock. Seaport Global Securities assumed coverage on shares of Tilray in a research report on Thursday, February 21st. They set a “neutral” rating and a $81.10 price target on the stock. Roth Capital raised shares of Tilray from a “neutral” rating to a “buy” rating in a research report on Wednesday, February 20th. Jefferies Financial Group set a $61.00 price target on shares of Tilray and gave the stock a “sell” rating in a research report on Tuesday, March 19th. Piper Jaffray Companies set a $90.00 price target on shares of Tilray and gave the stock a “buy” rating in a research report on Tuesday, March 19th. Finally, Vertical Research assumed coverage on shares of Tilray in a research report on Friday, April 12th. They set a “sell” rating on the stock. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $89.71.
Shares of NASDAQ TLRY opened at $43.88 on Friday. The firm has a market cap of $4.25 billion and a PE ratio of -53.51. Tilray Inc has a twelve month low of $20.10 and a twelve month high of $300.00. The company has a current ratio of 2.35, a quick ratio of 2.06 and a debt-to-equity ratio of 1.13.
Tilray (NASDAQ:TLRY) last announced its quarterly earnings results on Tuesday, May 14th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.02). The firm had revenue of $23.00 million for the quarter, compared to the consensus estimate of $20.50 million. Tilray had a negative return on equity of 43.71% and a negative net margin of 159.09%. Tilray’s revenue for the quarter was up 194.9% compared to the same quarter last year. As a group, equities analysts anticipate that Tilray Inc will post -0.8 earnings per share for the current fiscal year.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also: Roth IRA
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.